Antibiotics to Avoid During Pregnancy
The antibiotics that must be avoided during pregnancy include tetracyclines (especially doxycycline after the first trimester), aminoglycosides (gentamicin, tobramycin), fluoroquinolones, co-trimoxazole/trimethoprim-sulfamethoxazole (particularly first trimester and near term), metronidazole, dapsone, and erythromycin, with the strength of avoidance varying by trimester and specific fetal risks. 1
Strongly Contraindicated Throughout Pregnancy
Tetracyclines (Doxycycline, Minocycline)
- Doxycycline should be avoided during the second and third trimesters and at delivery due to tooth discoloration, transient suppression of bone growth, and potential congenital anomalies. 1
- Tetracyclines bind to fetal bones and teeth, causing permanent discoloration if used after the fifth week of pregnancy. 2, 3
- May exacerbate maternal fatty liver of pregnancy. 1
- If absolutely necessary in the first trimester only, use should be limited and not considered first-choice therapy. 1
Aminoglycosides (Gentamicin, Tobramycin - Systemic)
- Associated with eighth cranial nerve damage and theoretical nephrotoxicity in the fetus. 4
- Carry a small but significant risk of fetal ototoxicity. 2
- Should not be prescribed at any time during pregnancy except for life-threatening infections with gram-negative pathogens when other antibiotics have failed. 3
- Important caveat: Inhaled tobramycin has minimal systemic absorption and is considered compatible during pregnancy if required for clinical stability. 1
Avoid in Specific Trimesters
Co-trimoxazole (Trimethoprim-Sulfamethoxazole)
- Should be avoided during the first trimester and near term due to increased risk of preterm birth, low birthweight, and kernicterus. 1
- Sulfonamide use is associated with neonatal hyperbilirubinemia and fetal hemolytic anemia when used at delivery. 1
- Trimethoprim interferes with folic acid metabolism, potentially increasing risk of neural tube defects and cardiovascular abnormalities. 5
- May be "possibly safe" in the second trimester only if absolutely necessary with folic acid supplementation (at least 400 μg daily). 1, 5
Metronidazole
- Should be avoided due to increased risk of low birthweight and neuroblastoma. 1
- This represents a conditional recommendation with low-quality evidence, but the potential for serious fetal harm warrants avoidance. 1
Use with Extreme Caution (Generally Avoided)
Fluoroquinolones (Ciprofloxacin, Others)
- Most clinicians avoid during pregnancy and lactation due to animal studies showing fetal cartilage damage. 1
- Human data suggest the actual risk may be low, but these remain second-line agents. 1
- If a fluoroquinolone is absolutely indicated, ciprofloxacin should be the chosen agent. 1
- Classified as "possibly safe" but not recommended as first-line therapy. 1
Dapsone
- Should be avoided due to increased risk of preterm birth, low birthweight, and hemolysis. 1
- This is a conditional recommendation with very low-quality evidence. 1
Erythromycin
- Should be avoided due to increased risk of adverse outcomes including elevated liver enzymes. 1
- Erythromycin estolate specifically is avoided due to potential maternal hepatotoxicity. 1
- This represents a strong recommendation despite low-quality evidence. 1
Clarithromycin
- Produced adverse pregnancy outcomes in experimental animals, though human data suggest low risk. 1
- FDA labeling indicates it is not recommended for use in pregnant women except when no alternative therapy is appropriate. 6
- Classified as "probably safe" but should not be first-line. 1
Safe First-Line Alternatives
Preferred Antibiotics During Pregnancy
- Cephalexin (cephalosporin): Safe with moderate-quality evidence. 1
- Azithromycin (macrolide): Safe with moderate-quality evidence. 1
- Clindamycin: Safe with moderate-quality evidence. 1
- Amoxicillin and amoxicillin-clavulanate: Compatible, though avoid amoxicillin-clavulanate in women at risk of preterm delivery due to very low risk of necrotizing enterocolitis. 1
- Cefuroxime and other cephalosporins: Not teratogenic at usual therapeutic doses. 1
Critical Clinical Pitfalls
Common Mistakes to Avoid
- Do not assume inhaled aminoglycosides carry the same risk as systemic formulations—inhaled tobramycin is actually compatible. 1
- Do not use amoxicillin-clavulanate in women at risk for preterm delivery. 1
- Do not prescribe tetracyclines after the fifth week of pregnancy under any circumstances. 3
- Always supplement with folic acid (≥400 μg daily) if trimethoprim must be used. 5
Timing Considerations
- First trimester exposures carry the highest risk for congenital malformations (organogenesis period). 1
- Third trimester and delivery exposures risk neonatal complications (hyperbilirubinemia, kernicterus, hemolytic anemia). 1
- Second trimester may allow slightly more flexibility for certain agents like co-trimoxazole when safer alternatives have failed. 5